Category: testosterone
Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof…. Continue Reading →
BBC Menopause and testosterone replacement therapy
Over 900 specialist menopause physicians from around the world attended The European Menopause and Andropause Society conference held in Berlin on 15-17th May 2019. Numerous… Continue Reading →
Effects of testosterone therapy in women – new systematic review and meta-analysis
It has been over a decade since the last systematic review and meta-analysis on the effects of testosterone for women was conducted as an… Continue Reading →
Hypoactive Sexual Desire Disorder (HSDD) re-defined
In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created… Continue Reading →
Axiron® discontinued – Upgrade to AndroForte® 5
Axiron® discontinued – Upgrade to AndroForte® 5 Axiron 2% testosterone solution has been discontinued in Australia effective 4th December 2017 after Lilly terminated its… Continue Reading →
FDA acknowledges there is a medical need for treating female sexual dysfunction
In late October 2016 the US FDA released draft guidance for Industry on Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment. This document states ”… Continue Reading →
Federal Court Proceedings Demonstrate Risk To Compounding Pharmacies
MEDIA RELEASE 3rd August 2017 A recent Federal Court case highlights the very real risk and cost to Compounding Pharmacies who do not… Continue Reading →
EDUCATION: View presentations on testosterone management in men and women
EDUCATION View presentations on testosterone management in men and women In June 2017 the Lawley website added a ‘Health Professional Section’. This password protected learning area will… Continue Reading →
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months
The Testosterone and Exercise (TEX) Trial
Status: Study completed October 2018. Analysis of results underway. The University of Western Australia and Fiona Stanley Hospital are now recruiting for the TEX… Continue Reading →